JP2005519893A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519893A5
JP2005519893A5 JP2003559519A JP2003559519A JP2005519893A5 JP 2005519893 A5 JP2005519893 A5 JP 2005519893A5 JP 2003559519 A JP2003559519 A JP 2003559519A JP 2003559519 A JP2003559519 A JP 2003559519A JP 2005519893 A5 JP2005519893 A5 JP 2005519893A5
Authority
JP
Japan
Prior art keywords
beta
hydroxy
pregnane
5alpha
3beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003559519A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519893A (ja
Filing date
Publication date
Priority claimed from SE0104423A external-priority patent/SE0104423D0/xx
Application filed filed Critical
Publication of JP2005519893A publication Critical patent/JP2005519893A/ja
Publication of JP2005519893A5 publication Critical patent/JP2005519893A5/ja
Pending legal-status Critical Current

Links

JP2003559519A 2001-12-27 2002-12-20 Cns疾患の治療において使用するためのプレグナンステロイド Pending JP2005519893A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0104423A SE0104423D0 (sv) 2001-12-27 2001-12-27 Pregnane steroids and their use in the treatment of CNS disorders
PCT/SE2002/002423 WO2003059357A1 (en) 2001-12-27 2002-12-20 Pregnane steroids for use in the treatment of cns disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009256620A Division JP5289281B2 (ja) 2001-12-27 2009-11-10 Cns疾患の治療において使用するためのプレグナンステロイド

Publications (2)

Publication Number Publication Date
JP2005519893A JP2005519893A (ja) 2005-07-07
JP2005519893A5 true JP2005519893A5 (cg-RX-API-DMAC7.html) 2006-01-19

Family

ID=20286518

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003559519A Pending JP2005519893A (ja) 2001-12-27 2002-12-20 Cns疾患の治療において使用するためのプレグナンステロイド
JP2009256620A Expired - Fee Related JP5289281B2 (ja) 2001-12-27 2009-11-10 Cns疾患の治療において使用するためのプレグナンステロイド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009256620A Expired - Fee Related JP5289281B2 (ja) 2001-12-27 2009-11-10 Cns疾患の治療において使用するためのプレグナンステロイド

Country Status (10)

Country Link
US (2) US7960367B2 (cg-RX-API-DMAC7.html)
EP (2) EP2275109B1 (cg-RX-API-DMAC7.html)
JP (2) JP2005519893A (cg-RX-API-DMAC7.html)
CN (3) CN101601674A (cg-RX-API-DMAC7.html)
AU (3) AU2002359202C1 (cg-RX-API-DMAC7.html)
CA (1) CA2468248C (cg-RX-API-DMAC7.html)
DK (1) DK1458399T3 (cg-RX-API-DMAC7.html)
ES (1) ES2394639T3 (cg-RX-API-DMAC7.html)
SE (1) SE0104423D0 (cg-RX-API-DMAC7.html)
WO (1) WO2003059357A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2413516C2 (ru) * 2004-11-18 2011-03-10 Умекрин Аб Гамк-стероидные антагонисты и их применение в лечении нарушений цнс
DK1812009T3 (da) * 2004-11-18 2013-08-05 Umecrine Ab GABA-steroidantagonister og deres anvendelse til behandling af CNS-lidelser
EP2711372A1 (en) 2006-11-21 2014-03-26 Umecrine AB The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders
US20090269795A1 (en) * 2007-03-09 2009-10-29 The Research Foundation Of State University Of New York Mutant alpha4betadelta GABAA receptor and methods of treating anxiety or irritability
CN101585862B (zh) * 2008-05-20 2014-12-17 梅克芳股份公司 甾族化合物
JP5687287B2 (ja) 2010-01-14 2015-03-18 ウメクライン ムード エービー 改善された保存性及び溶解特性を有する3−ベータ−ヒドロキシ−5−アルファ−プレグナン−20−オンを含有する薬学的組成物
CN106983754A (zh) 2011-05-20 2017-07-28 国家医疗保健研究所 Cb1受体拮抗剂
RU2667065C2 (ru) 2012-11-28 2018-09-14 Энсэрм (Энститю Насьональ Де Ля Санте Э Де Ля Решерш Медикаль) Производные прегненолона
CN106163528A (zh) 2014-01-29 2016-11-23 梅克芳识别有限公司 用于治疗肝脑病的甾族化合物
JOP20200195A1 (ar) * 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
TWI748936B (zh) 2015-01-12 2021-12-11 瑞典商優鎂奎認知Ab公司 新穎化合物
US10278977B2 (en) 2016-06-06 2019-05-07 Umecrine Cognition Ab Methods for treating hypersomnolence
US10933014B2 (en) * 2017-01-09 2021-03-02 Asarina Pharma Ab Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof
WO2018147791A1 (en) 2017-02-10 2018-08-16 Asarina Pharma Ab 3-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremor
CN110430883A (zh) 2017-02-10 2019-11-08 阿沙里那制药公司 用于医学治疗的3β-羟基-5α-孕烷-20-酮
CN111918657A (zh) * 2018-04-05 2020-11-10 阿沙里那制药有限公司 用于治疗物质戒断障碍的gaba-a拮抗剂
US11969434B1 (en) 2022-08-29 2024-04-30 Lipocine Inc. Oral allopregnanolone compositions and methods of use
WO2023083978A1 (en) 2021-11-10 2023-05-19 Umecrine Ab 3.alpha.-substituted 3.beta.-hydroxy 17-oximated androstane compound for modulation of the alpha-3 subtype of the gaba-a receptor
WO2023083980A1 (en) 2021-11-10 2023-05-19 Umecrine Ab Steroid as a modulator of gabaa receptor
WO2023083979A1 (en) * 2021-11-10 2023-05-19 Umecrine Ab 3.beta.-hydroxy, 3.alpha.-ethyl steroids for modulation of the alpha-3 subtype of the gaba-a receptor
US12186327B2 (en) 2022-08-29 2025-01-07 Lipocine Inc. Oral allopregnanolone compositions and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5439900A (en) * 1993-02-25 1995-08-08 Bukusoglu; Cuneyt Methods and compositions for providing analgesia and enhanced anesthesia
US5939545A (en) 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
US5767117A (en) 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
CN1254283A (zh) * 1997-05-02 2000-05-24 美国家用产品公司 孕烷-3-醇-20-酮
PT980381E (pt) 1997-05-02 2003-12-31 Wyeth Corp Sais farmaceuticamente aceitaveis de ester 3-sulfato de 5-alfa-pregn-16-en-3-beta-ol-20-ona com actividade de progesterona e uteis no tratamento de perturbacoes do snc
CN1254342A (zh) * 1997-05-02 2000-05-24 美国家用产品公司 用作孕激素和治疗CNS疾病的5α-孕烷-3β,16α-二醇-20-酮3-硫酸酯的可药用盐
CN1270718C (zh) * 1998-03-11 2006-08-23 托布乔恩·贝克斯托罗姆 表别孕烷醇酮在制备治疗甾族化合物诱导的疾病的药物中的应用
CZ20011343A3 (cs) 1998-10-13 2002-04-17 American Home Products Corporation Pregnanglukuronidy
US20020072509A1 (en) * 2000-10-11 2002-06-13 Stein Donald Gerald Methods for the treatment of a traumatic central nervous system injury

Similar Documents

Publication Publication Date Title
JP5289281B2 (ja) Cns疾患の治療において使用するためのプレグナンステロイド
JP2505944B2 (ja) (S)―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物
JP2013523683A5 (cg-RX-API-DMAC7.html)
JP2001518509A5 (cg-RX-API-DMAC7.html)
JP6753860B2 (ja) リルゾールの舌下製剤
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
RU2010123028A (ru) Кортикостероиды для лечения диареи, индуцированной эпотилоном или производным эпотилона
JP2017535612A (ja) リルゾールの舌下投与
RU2745687C1 (ru) Способ лечения эндометриоза с болевым синдромом и фармацевтическая композиция для его реализации
RU2007130700A (ru) Комбинация соединений метилксантина и стероидов для лечения хронических распираторных заболеваний
TW201016209A (en) Intranasal compositions, dosage forms and methods of treatments
JP2026035701A5 (cg-RX-API-DMAC7.html)
JP2023523569A5 (cg-RX-API-DMAC7.html)
JP2009508854A (ja) 睡眠時呼吸障害の予防及び治療方法及び手段
CN110062625A (zh) 尼达尼布通过与奥达特罗共给予用于治疗间质性肺病的方法
MX2024006271A (es) Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
CA2538419A1 (en) Use of ciclesonide for the treatment of respiratory diseases
Balzano et al. Leukotriene receptor antagonists in the treatment of asthma: an update
WO2017148129A1 (zh) 一种用于治疗恶病质的药物组合物及其应用
JP2019507786A5 (cg-RX-API-DMAC7.html)
JP2025506201A5 (cg-RX-API-DMAC7.html)
ES2320662T3 (es) Hormonoterapia restitutiva y tratamiento para la depresion con dienogest.
JP2008533079A5 (cg-RX-API-DMAC7.html)
JP4914368B2 (ja) Gaba−ステロイド拮抗剤およびcns疾患の治療のためのその使用
UA96770C2 (uk) Спосіб лікування розладу терморегуляторної функції за допомогою пароксетину